Möchten Sie immer auf dem neuesten Stand bleiben?

MONTRÉAL, 07 avr. 2026 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (« Cannara », « la Société », « nous » ou « notre ») (TSX : LOVE) (OTCQX : LOVFF) (FRA : 8CB0), producteur verticalement intégré...

Cannara Biotech Inc. announced it will release its fiscal Q2 2026 financial results, for the period ending February 28, 2026, on April 14, 2026, at 7:00AM

Blue Cross and Blue Shield of Minnesota Announces 2025 Financials

Aptera Motors (SEV) reports Q4 adjusted net loss of $8.7M, raised $17.1M in 2026 to advance validation builds toward production.

Achieve also Announces Partnership with U.S.-based Adare Pharma Solutions for Cytisinicline Manufacturing Conference Call Scheduled for 8:30 AM EDT Today, March 24, 2026 SEATTLE and VANCOUVER,...

– Successfully licensed helicase-primase inhibitor program for recurrent genital herpes to Gilead, including candidates ABI-5366 and ABI-1179, following positive Phase 1b interim data; development...

BOISE, Idaho, March 18, 2026 (GLOBE NEWSWIRE) -- Micron Technology, Inc. (Nasdaq: MU) today announced results for its second quarter of fiscal 2026, which ended February 26, 2026. Fiscal Q2 2026...

SEATTLE and VANCOUVER, British Columbia, March 17, 2026 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global...

COPENHAGEN, Denmark – March 16, 2026. Novonesis has completed a EUR 1.7 billion bond issuance, with significant interest from a broad group of investors. The transaction was primarily undertaken to...

XOMA Royalty will conduct a webcast to review 4Q and full year 2025 financial results